Mechanisms of CD8+ T cell‐mediated suppression of HIV/SIV replication

In this article, we summarize the role of CD8+ T cells during natural and antiretroviral therapy (ART)‐treated HIV and SIV infections, discuss the mechanisms responsible for their suppressive activity, and review the rationale for CD8+ T cell‐based HIV cure strategies. Evidence suggests that CD8+ T ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of immunology 2018-06, Vol.48 (6), p.898-914
Hauptverfasser: McBrien, Julia Bergild, Kumar, Nitasha A., Silvestri, Guido
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this article, we summarize the role of CD8+ T cells during natural and antiretroviral therapy (ART)‐treated HIV and SIV infections, discuss the mechanisms responsible for their suppressive activity, and review the rationale for CD8+ T cell‐based HIV cure strategies. Evidence suggests that CD8+ T cells are involved in the control of virus replication during HIV and SIV infections. During early HIV infection, the cytolytic activity of CD8+ T cells is responsible for control of viremia. However, it has been proposed that CD8+ T cells also use non‐cytolytic mechanisms to control SIV infection. More recently, CD8+ T cells were shown to be required to fully suppress virus production in ART‐treated SIV‐infected macaques, suggesting that CD8+ T cells are involved in the control of virus transcription in latently infected cells that persist under ART. A better understanding of the complex antiviral activities of CD8+ T cells during HIV/SIV infection will pave the way for immune interventions aimed at harnessing these functions to target the HIV reservoir. While CD8+ T cells are an essential component of HIV/SIV control, the specific mechanisms contributing to their suppressive activity are yet to be fully elucidated. In this review, we discuss the numerous fates and functions of CD8+ T cells during both natural and treated HIV/SIV infection, and provide rationale for CD8+ T cell‐based HIV cure strategies.
ISSN:0014-2980
1521-4141
DOI:10.1002/eji.201747172